|
SECTION I Overview of the Laboratory |
|
|
2 | (116) |
|
Chapter 1 The Clinical Laboratory |
|
|
5 | (20) |
|
|
6 | (2) |
|
|
8 | (1) |
|
Why Is Laboratory Testing Performed? |
|
|
9 | (1) |
|
The Role of the Medical Assistant in the Laboratory |
|
|
10 | (1) |
|
Information Flow in the Clinical Laboratory |
|
|
10 | (11) |
|
Three Phases of Laboratory Testing |
|
|
21 | (4) |
|
Chapter 2 Regulations Governing Laboratory Personnel |
|
|
25 | (10) |
|
|
26 | (3) |
|
Clinical Laboratory Improvement Amendment of 1988 |
|
|
29 | (6) |
|
Chapter 3 Laboratory Safety and Preventing the Spread of Disease |
|
|
35 | (28) |
|
Infection Control and Laboratory Safety |
|
|
37 | (1) |
|
Core Concepts of Infection Control |
|
|
37 | (11) |
|
|
48 | (7) |
|
Diseases Caused by Bloodborne Pathogens in the Laboratory Setting |
|
|
55 | (3) |
|
Postexposure Follow-up Procedure |
|
|
58 | (5) |
|
Chapter 4 Assuring Quality |
|
|
63 | (20) |
|
Assuring Quality in the Laboratory |
|
|
64 | (1) |
|
Quality Control and Quality Assurance |
|
|
64 | (1) |
|
|
65 | (8) |
|
Other Methods of Assuring Laboratory Quality |
|
|
73 | (10) |
|
Chapter 5 Legal and Ethical Issues |
|
|
83 | (12) |
|
Legal and Ethical Issues in the Laboratory Environment |
|
|
84 | (1) |
|
|
84 | (1) |
|
Legal Concepts Affecting Patient Interactions |
|
|
85 | (3) |
|
Health Information Portability and Accountability Act |
|
|
88 | (2) |
|
|
90 | (2) |
|
Risk Management and the Medical Assistant |
|
|
92 | (3) |
|
Chapter 6 Laboratory Equipment |
|
|
95 | (23) |
|
|
96 | (11) |
|
Equipment Used for Automated Clinical Laboratory Improvement Amendment-Waived Testing |
|
|
107 | (11) |
|
SECTION II Specimen Collection and Processing |
|
|
118 | (138) |
|
Chapter 7 Overview of Specimen Collection and Processing |
|
|
121 | (12) |
|
|
122 | (3) |
|
|
125 | (1) |
|
|
126 | (1) |
|
Specimen Collection at Home |
|
|
127 | (1) |
|
Items That Must Be Documented With Specimen Collection |
|
|
127 | (1) |
|
|
128 | (1) |
|
|
128 | (5) |
|
Chapter 8 Collection and Processing of Blood Samples |
|
|
133 | (62) |
|
Anatomy and Physiology of the Cardiovascular System |
|
|
135 | (3) |
|
|
138 | (2) |
|
Contraindications and Areas to Avoid |
|
|
140 | (3) |
|
|
143 | (3) |
|
Methods Used for Venipuncture |
|
|
146 | (1) |
|
|
147 | (3) |
|
Order of Draw for Venipuncture |
|
|
150 | (1) |
|
|
150 | (2) |
|
Preparation for Blood Collection |
|
|
152 | (1) |
|
|
153 | (31) |
|
Potential Negative Outcomes of Venipuncture and Capillary Puncture |
|
|
184 | (2) |
|
Other Processing Procedures |
|
|
186 | (1) |
|
Preparation of a Peripheral Blood Smear for Staining |
|
|
186 | (3) |
|
|
189 | (6) |
|
Chapter 9 Collection and Processing of Urine Samples |
|
|
195 | (20) |
|
|
196 | (14) |
|
Urine Specimen Processing |
|
|
210 | (5) |
|
Chapter 10 Collection and Processing of Samples for Microbial Studies |
|
|
215 | (41) |
|
Microbiology Sample Collection Guidelines |
|
|
218 | (5) |
|
Detailed Microbiology Sample Collection Procedures |
|
|
223 | (17) |
|
Special Sample Collection and Processing Procedures |
|
|
240 | (4) |
|
Processing Microbiology Samples |
|
|
244 | (7) |
|
Microbiology Test Results |
|
|
251 | (5) |
|
SECTION III Hematology and Coagulation |
|
|
256 | (76) |
|
Chapter 11 Overview of Hematology, Nikki A. Marhefka |
|
|
259 | (10) |
|
Hematopoiesis---Blood Cell Formation |
|
|
260 | (3) |
|
Types of Blood Cells in the Circulating Blood |
|
|
263 | (3) |
|
Analysis of the Formed Elements |
|
|
266 | (3) |
|
Chapter 12 Complete Blood Count With Differential, Nikki A. Marhefka |
|
|
269 | (16) |
|
|
270 | (9) |
|
Automated Analyzers for Complete Blood Count Testing |
|
|
279 | (6) |
|
Chapter 13 Hemoglobin and Hematocrit, Nikki A. Marhefka |
|
|
285 | (18) |
|
|
286 | (1) |
|
|
287 | (1) |
|
|
288 | (5) |
|
|
293 | (6) |
|
The Relationship of Hemoglobin and Hematocrit Values |
|
|
299 | (1) |
|
|
299 | (4) |
|
Chapter 14 Erythrocyte Sedimentation Rate, Nikki A. Marhefka |
|
|
303 | (10) |
|
Erythrocyte Sedimentation Rate |
|
|
304 | (1) |
|
Plasma Proteins Affecting the Erythrocyte Sedimentation Rate |
|
|
304 | (1) |
|
The Influence of Red Blood Cells on the Erythrocyte Sedimentation Rate |
|
|
305 | (1) |
|
|
305 | (1) |
|
Clinical Significance of Erythrocyte Sedimentation Rate Testing |
|
|
305 | (1) |
|
Erythrocyte Sedimentation Rate Determination |
|
|
306 | (1) |
|
Potential Sources of Error for the Erythrocyte Sedimentation Rate Procedure |
|
|
307 | (6) |
|
Chapter 15 Coagulation Studies |
|
|
313 | (19) |
|
Purpose of Coagulation Studies |
|
|
314 | (1) |
|
Mechanisms of Blood Clotting |
|
|
315 | (1) |
|
Disorders Diagnosed or Monitored With Laboratory Coagulation Tests |
|
|
316 | (2) |
|
Laboratory Tests Used to Diagnose Coagulation Disorders or Monitor Anticoagulant Therapy |
|
|
318 | (9) |
|
Specimen Requirements for Coagulation Testing |
|
|
327 | (5) |
|
SECTION IV Clinical Chemistry |
|
|
332 | (56) |
|
Chapter 16 Overview of Clinical Chemistry |
|
|
335 | (14) |
|
|
336 | (1) |
|
Specimen Types Used for Clinical Chemistry Analysis |
|
|
337 | (1) |
|
CLIA-Waived Clinical Chemistry Test |
|
|
338 | (2) |
|
Other Common Clinical Chemistry Tests |
|
|
340 | (2) |
|
|
342 | (1) |
|
Potential Sources of Error |
|
|
342 | (7) |
|
Chapter 17 Glucose Testing |
|
|
349 | (22) |
|
Glucose Utilization and Control Mechanisms |
|
|
351 | (1) |
|
Pathophysiology of Glucose Metabolism |
|
|
352 | (4) |
|
Types of Glucose Tests Performed |
|
|
356 | (5) |
|
|
361 | (10) |
|
Chapter 18 Other Select Chemistry Tests |
|
|
371 | (17) |
|
|
372 | (6) |
|
|
378 | (10) |
|
|
388 | (68) |
|
|
391 | (10) |
|
Historical Perspective of Urinalysis |
|
|
392 | (1) |
|
Anatomy and Physiology of the Urinary System |
|
|
393 | (3) |
|
Sequence of Urine Production and Excretion |
|
|
396 | (1) |
|
Clinical Significance of Urine Testing Results |
|
|
396 | (2) |
|
Quality Assurance for Urine Testing Procedures |
|
|
398 | (1) |
|
Standard Precautions Used When Analyzing Urine Specimens |
|
|
398 | (1) |
|
|
398 | (3) |
|
Chapter 20 Physical Characteristics of Urine |
|
|
401 | (12) |
|
Physical Characteristics of Urine |
|
|
402 | (5) |
|
Potential Sources of Error |
|
|
407 | (6) |
|
Chapter 21 Chemical Examination of Urine and Feces |
|
|
413 | (26) |
|
Urine Analytes and Their Clinical Significance |
|
|
414 | (6) |
|
Potential Sources of Error |
|
|
420 | (2) |
|
|
422 | (1) |
|
Quality Control Procedures |
|
|
422 | (1) |
|
|
422 | (2) |
|
Confirmatory Urine Testing |
|
|
424 | (6) |
|
Fecal Occult Blood Testing |
|
|
430 | (9) |
|
Chapter 22 Microscopic Examination of Urine |
|
|
439 | (17) |
|
Reasons for Performing Urine Microscopic Examinations |
|
|
440 | (1) |
|
Common Formed Elements in the Urine and Their Clinical Significance |
|
|
440 | (7) |
|
Methods Used for Urine Microscopic Examinations |
|
|
447 | (1) |
|
Reporting Urine Microscopic Results |
|
|
447 | (5) |
|
Role of the Medical Assistant in Microscopic Urine Examination Procedures |
|
|
452 | (1) |
|
Quality Control and Quality Assurance Procedures for Urine Microscopic Examinations |
|
|
452 | (4) |
|
|
456 | (35) |
|
|
459 | (14) |
|
|
460 | (1) |
|
|
461 | (3) |
|
|
464 | (1) |
|
Failure of Our Immune Systems |
|
|
465 | (1) |
|
|
465 | (3) |
|
Immunology Testing Methods |
|
|
468 | (1) |
|
Common Serology Tests Performed in Reference or Hospital Laboratories |
|
|
468 | (1) |
|
CLIA-Waived Tests Commonly Performed in the Physician Office Laboratory |
|
|
469 | (4) |
|
Chapter 24 Immunological Based Rapid Testing |
|
|
473 | (18) |
|
Immunology Methods and Procedures |
|
|
474 | (1) |
|
|
475 | (1) |
|
Common CLIA-Waived Rapid Tests and Their Clinical Significance |
|
|
476 | (15) |
Appendix A Reference Ranges |
|
491 | (2) |
Appendix B Answers to Test Your Knowledge Questions |
|
493 | (12) |
Appendix C Tube Guide for BD Vacutainer Venous Blood Collection |
|
505 | (2) |
Glossary |
|
507 | (22) |
Index |
|
529 | |